Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · IEX Real-Time Price · USD
+0.050 (3.09%)
At close: Jun 21, 2024, 4:00 PM
+0.040 (2.40%)
After-hours: Jun 21, 2024, 7:46 PM EDT

Coherus BioSciences Revenue

Coherus BioSciences had revenue of $301.87M in the twelve months ending March 31, 2024, with 64.63% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $77.06M with 137.58% year-over-year growth. In the year 2023, Coherus BioSciences had annual revenue of $257.24M with 21.89% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
191.59M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023257.24M46.20M21.89%
Dec 31, 2022211.04M-115.51M-35.37%
Dec 31, 2021326.55M-149.27M-31.37%
Dec 31, 2020475.82M119.75M33.63%
Dec 31, 2019356.07M--
Dec 31, 20180--
Dec 31, 20171.56M-188.55M-99.18%
Dec 31, 2016190.11M160.07M532.82%
Dec 31, 201530.04M-1.07M-3.42%
Dec 31, 201431.11M28.36M1,030.72%
Dec 31, 20132.75M852.00K44.87%
Dec 31, 20121.90M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 321.52M
Akebia Therapeutics 187.23M
OptimizeRx 78.21M
2seventy bio 71.20M
NeuroPace 69.07M
Genfit 42.42M
Revenue Rankings